Several studies have identified tumor-derived EVs carrying proteins such as CD9, tumor susceptibility gene 101 (TSG101), and heat shock protein 70 (HSP70) as potential biomarkers for GBM classification and prognosis [16,41]. This evidence concerns the gene TSG101 and glioblastoma.